Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion
November 29, 2016 at 10:39 AM EST
Biopharma companies are poised to benefit from U.S. tax reform related to repatriation of OUS (Outside the United States) cash or a rate ...